Circulating tumor DNA is prognostic for disease-free survival in patients with metastatic colorectal cancer undergoing definitive therapy

被引:0
|
作者
Naleid, N. [1 ]
Zablonski, K. [1 ]
Odonnell, C. [2 ]
Siripoon, T. [3 ]
Conces, M. L. [4 ]
Lumish, M. [4 ]
Selfridge, J. E. [4 ]
Bajor, D. [4 ]
Chakrabarti, S. [4 ]
Jin, Z. [2 ]
Mahipal, A. [4 ]
机构
[1] Univ Hosp, Case Western Reserve Univ, Dept Med, Cleveland, OH USA
[2] Mayo Clin, Dept Med Oncol, Rochester, MN USA
[3] Mahidol Univ, Fac Med, Ramathibodi Hosp, Dept Med Oncol, Bangkok, Thailand
[4] Case Western Reserve Univ, Univ Hosp, Seidman Canc Ctr, Dept Med,Div Hematol Oncol, Cleveland, OH USA
关键词
D O I
10.1016/j.annonc.2024.05.110
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
99P
引用
下载
收藏
页码:S47 / S47
页数:1
相关论文
共 50 条
  • [41] PROGNOSTIC FACTORS FOR SURVIVAL AND DISEASE-FREE SURVIVAL IN HEPATIC METASTASES FROM COLORECTAL-CANCER TREATED BY RESECTION
    DOCI, R
    BIGNAMI, P
    MONTALTO, F
    GENNARI, L
    TUMORI JOURNAL, 1995, 81 (03): : 143 - 146
  • [42] The Effect of Obstruction and Perforation on Colorectal Cancer Disease-Free Survival
    Yik-Hong Ho
    Simon K. K. Siu
    Petra Buttner
    Andrew Stevenson
    John Lumley
    Russel Stitz
    World Journal of Surgery, 2010, 34 : 1091 - 1101
  • [43] The Effect of Obstruction and Perforation on Colorectal Cancer Disease-Free Survival
    Ho, Yik-Hong
    Siu, Simon K. K.
    Buttner, Petra
    Stevenson, Andrew
    Lumley, John
    Stitz, Russel
    WORLD JOURNAL OF SURGERY, 2010, 34 (05) : 1091 - 1101
  • [44] Plasma cell-free DNA and fraction of circulating KRAS mutations as prognostic in patients with metastatic colorectal cancer.
    Sefrioui, David
    Vasseur, Nasrin
    Sesbouee, Richard
    Blanchard, France
    Oden-Gangloff, Alice
    Sabourin, Jean-Christophe
    Frebourg, Thierry
    Michel, Pierre
    Di Fiore, Frederic
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [45] Prognostic factors for disease-free and overall survival in patients treated with chemoradiation therapy for locally advanced pancreatic cancer
    Krishnan, S.
    Rana, V.
    Janjan, N.
    Abbruzzese, J.
    Das, P.
    Delclos, M.
    Varadhachary, G.
    Evans, D.
    Wolff, R.
    Crane, C.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S527 - S527
  • [46] Prognostic role of methylated free circulating DNA in colorectal cancer
    Philipp, Alexander B.
    Stieber, Petra
    Nagel, Dorothea
    Neumann, Jens
    Spelsberg, Fritz
    Jung, Andreas
    Lamerz, Rolf
    Herbst, Andreas
    Kolligs, Frank T.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (10) : 2308 - 2319
  • [47] Free circulating DNA as potential prognostic factor in colorectal cancer
    Cassinotti, Elisa
    Boni, Luigi
    Rausei, Stefano
    Marzorati, Alessandro
    Dionigi, Gianlorenzo
    Dionigi, Renzo
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2012, 215 (03) : S31 - S32
  • [48] Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer
    Magri, Valentina
    Marino, Luca
    Nicolazzo, Chiara
    Gradilone, Angela
    De Renzi, Gianluigi
    De Meo, Michela
    Gandini, Orietta
    Sabatini, Arianna
    Santini, Daniele
    Cortesi, Enrico
    Gazzaniga, Paola
    CELLS, 2023, 12 (08)
  • [49] Circulating tumor cells (CTC) predict progression free (PFS) and overall survival (OS) in patients with metastatic colorectal cancer
    Meropol, N. J.
    Cohen, S. J.
    Iannotti, N.
    Saidman, B. H.
    Sabbath, K. D.
    Miller, M. C.
    Doyle, G. V.
    Tissing, H.
    Terstappen, L. W. M. M.
    Punt, C. J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Assessment of Circulating Tumor DNA in Patients with Metastatic Colorectal Cancer Treated with Cetuximab Monotherapy
    Angus, L.
    van Helden, E. J.
    van Es, S. C.
    Boon, E.
    van Herpen, C. M. L.
    de Groot, D. J.
    van Oordt, C. W. Menke-van der Houven
    Sleijfer, S.
    Verheul, H. M. W.
    Jansen, M. P. H. M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (03): : S5 - S5